BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esmaeili A, Mirzazadeh A, Carter GM, Esmaeili A, Hajarizadeh B, Sacks HS, Page KA. Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis. J Viral Hepat 2017;24:117-27. [PMID: 27790803 DOI: 10.1111/jvh.12628] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Iversen J, Dore GJ, Catlett B, Cunningham P, Grebely J, Maher L. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia. Journal of Hepatology 2019;70:33-9. [DOI: 10.1016/j.jhep.2018.09.030] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 14.3] [Reference Citation Analysis]
2 Kushner T, Chappell CA, Kim AY. Testing for Hepatitis C in Pregnancy: the Time has Come for Routine Rather than Risk-based. Curr Hepatol Rep 2019;18:206-15. [PMID: 31890461 DOI: 10.1007/s11901-019-00468-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Karlsson N, Kåberg M, Berglund T, Hammarberg A, Widman L, Ekström AM. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden. Int J Drug Policy 2021;90:103059. [PMID: 33360734 DOI: 10.1016/j.drugpo.2020.103059] [Reference Citation Analysis]
4 Sharhani A, Mehrabi Y, Noroozi A, Nasirian M, Higgs P, Hajebi A, Hamzeh B, Khademi N, Noroozi M, Shakiba E, Etemad K. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.58739] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
5 Balaeva T, Grjibovski AM, Samodova O, Sannikov A, Klouman E. Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study. Int J Circumpolar Health 2019;78:1648970. [PMID: 31370746 DOI: 10.1080/22423982.2019.1648970] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9:CD012021. [PMID: 28922449 DOI: 10.1002/14651858.cd012021.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 77] [Article Influence: 5.8] [Reference Citation Analysis]
7 Minoyan N, Høj SB, Jutras-Aswad D, Vlad D, Martel-Laferrière V, Sylvestre MP, Bruneau J. Gender-specific associations between psychological distress and injecting risk behaviours among people who inject drugs in Montreal, Canada. Int J Drug Policy 2021;:103319. [PMID: 34154905 DOI: 10.1016/j.drugpo.2021.103319] [Reference Citation Analysis]
8 Jain JP, Strathdee SA, West BS, Gonzalez-Zuniga P, Rangel G, Pitpitan EV. Sex differences in the multilevel determinants of injection risk behaviours among people who inject drugs in Tijuana, Mexico. Drug Alcohol Rev 2020;39:898-907. [PMID: 32794626 DOI: 10.1111/dar.13134] [Reference Citation Analysis]
9 Saing CH, Prem K, Uk P, Chhoun P, Chann N, Tuot S, Mun P, Yi S. Risk factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia. Int J Drug Policy 2020;86:102974. [PMID: 33068831 DOI: 10.1016/j.drugpo.2020.102974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Godin A, Kronfli N, Cox J, Alary M, Maheu-Giroux M. The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada. Int J Drug Policy 2021;88:102738. [PMID: 32278651 DOI: 10.1016/j.drugpo.2020.102738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
11 Rojas Rojas T, Di Beo V, Delorme J, Barre T, Mathurin P, Protopopescu C, Bailly F, Coste M, Authier N, Carrieri MP, Rolland B, Marcellin F. Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project. Int J Drug Policy 2019;72:61-8. [PMID: 31129024 DOI: 10.1016/j.drugpo.2019.05.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative. Clin Infect Dis 2018;66:20-8. [PMID: 29020200 DOI: 10.1093/cid/cix768] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
13 Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, Beyrer C. The opioid crisis and HIV in the USA: deadly synergies. Lancet 2021;397:1139-50. [PMID: 33617769 DOI: 10.1016/S0140-6736(21)00391-3] [Cited by in Crossref: 7] [Article Influence: 7.0] [Reference Citation Analysis]
14 Larney S, Madden A, Marshall AD, Martin NK, Treloar C. A gender lens is needed in hepatitis C elimination research. International Journal of Drug Policy 2022;103:103654. [DOI: 10.1016/j.drugpo.2022.103654] [Reference Citation Analysis]
15 Pradat P, Virlogeux V, Trépo E. Epidemiology and Elimination of HCV-Related Liver Disease. Viruses 2018;10:E545. [PMID: 30301201 DOI: 10.3390/v10100545] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
16 Martinello M, Dore GJ, Matthews GV, Grebely J. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs. Infect Dis Clin North Am 2018;32:371-93. [PMID: 29778261 DOI: 10.1016/j.idc.2018.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
17 Mehrabi Y, Etemad K, Noroozi A, Higgs P, Nasirian M, Sharhani A, Khademi N, Hajebi A, Noroozi M, Shakiba E, Hamzeh B, Azizmohammad Looha M. Correlates of injecting paraphernalia sharing among male drug injectors in Kermanshah, Iran: implications for HCV prevention. Journal of Substance Use 2020;25:330-5. [DOI: 10.1080/14659891.2019.1698670] [Reference Citation Analysis]
18 Mackesy-Amiti ME, Boodram B, Handanagic S, Paz-Bailey G, Prachand NG, Broz D; NHBS Study Group. Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women Who Inject Drugs Across 20 US Cities. J Acquir Immune Defic Syndr 2018;79:305-14. [PMID: 30044301 DOI: 10.1097/QAI.0000000000001816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Martinello M, Hajarizadeh B, Grebely J, Dore GJ, Matthews GV. Management of acute HCV infection in the era of direct-acting antiviral therapy. Nat Rev Gastroenterol Hepatol. 2018;15:412-424. [PMID: 29773899 DOI: 10.1038/s41575-018-0026-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
20 Fortier E, Høj SB, Sylvestre MP, Artenie AA, Minoyan N, Jutras-Aswad D, Grebely J, Bruneau J. Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada. Int J Drug Policy 2021;96:103439. [PMID: 34518099 DOI: 10.1016/j.drugpo.2021.103439] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Watts T, Lauver D, Snedden T, Zahner S. Risks for acquiring hepatitis C virus among women in the United States. Public Health Nurs 2021;38:309-20. [PMID: 33749074 DOI: 10.1111/phn.12892] [Reference Citation Analysis]
22 de Brito RJVC, da Silva LF, Santos MB, de Moura PMMF, de Souza CDF, do Carmo RF. A time series analysis of detection and mortality of hepatitis C in Brazil, 2008–2018. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07063-5] [Reference Citation Analysis]
23 Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer J. Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis 2020;70:2199-205. [PMID: 31631215 DOI: 10.1093/cid/ciz661] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N. Immunogenetics of new onset diabetes after transplantation in Kuwait. Diabetes Metab Syndr Obes 2019;12:731-42. [PMID: 31190933 DOI: 10.2147/DMSO.S195859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Van Baelen L, Plettinckx E, Antoine J, Gremeaux L. Prevalence of HCV among people who inject drugs in Brussels-a respondent-driven sampling survey. Harm Reduct J 2020;17:11. [PMID: 32085742 DOI: 10.1186/s12954-020-00358-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Leung J, Peacock A, Colledge S, Grebely J, Cunningham EB, Hickman M, Vickerman P, Stone J, Trickey A, Dumchev K, Lynskey M, Hines L, Griffiths P, Mattick RP, Degenhardt L, Larney S. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators? J Infect Dis 2019;220:78-90. [PMID: 30726973 DOI: 10.1093/infdis/jiz058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
27 Akiyama MJ, Cleland CM, Lizcano JA, Cherutich P, Kurth AE. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study. Lancet Infect Dis 2019;19:1255-63. [PMID: 31540840 DOI: 10.1016/S1473-3099(19)30264-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Cao S, Liu F, Wang T, Tan Y, Liu S, Liu Y, Gao L, Chen L. New patterns emerge after a sustained increase in the incidence of hepatitis C virus infection from 2004 to 2017: a joinpoint regression analysis. Public Health 2019;170:49-56. [PMID: 30928613 DOI: 10.1016/j.puhe.2019.01.014] [Reference Citation Analysis]
29 Parent S, Salters K, Awendila L, Ti L. Hepatitis C and pregnancy outcomes: a systematic review protocol. BMJ Open 2018;8:e024288. [PMID: 30580273 DOI: 10.1136/bmjopen-2018-024288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Rich NE, Murphy CC, Yopp AC, Tiro J, Marrero JA, Singal AG. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Aliment Pharmacol Ther 2020;52:701-9. [PMID: 32598091 DOI: 10.1111/apt.15917] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
31 Felsher M, Tobin KE, Sulkowski M, Latkin C, Falade-Nwulia O. HCV communication within ego-centric networks of men and women who inject drugs. Drug Alcohol Depend 2021;229:109157. [PMID: 34740020 DOI: 10.1016/j.drugalcdep.2021.109157] [Reference Citation Analysis]
32 Damas J, Storm M, Pandey LR, Marrone G, Deuba K. Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study. Ther Adv Infect Dis 2021;8:20499361211062107. [PMID: 34881024 DOI: 10.1177/20499361211062107] [Reference Citation Analysis]
33 Hall EW, Rosenberg ES, Sullivan PS. Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. BMC Infect Dis 2018;18:224. [PMID: 29769036 DOI: 10.1186/s12879-018-3133-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
34 Morris MD, Montgomery ME, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA. A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners. Subst Use Misuse 2018;53:1281-7. [PMID: 29286888 DOI: 10.1080/10826084.2017.1404105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
35 Tschann M, Wright T, Lusk H, Giorgio W, Colon A, Kaneshiro B. Understanding the Family Planning Needs of Female Participants in a Syringe Exchange Program: A Needs Assessment and Pilot Project. J Addict Med 2019;13:366-71. [PMID: 31589180 DOI: 10.1097/ADM.0000000000000508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]